--- a
+++ b/clusters/9knumclustersv2/clust_1469.txt
@@ -0,0 +1,40 @@
+Patient has pleural effusion, ascites, or pericardial fluid requiring drainage Note: Patient who had drain removal ?  days prior to planned first dose of study drug and has no sign of worsening is eligible
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring repeated drainage more than once every  days
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
+Uncontrolled tumor-related pain; pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures; or, hypercalcemia or symptomatic hypercalcemia requiring continued use of bisphosphonate therapy or denosumab.
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring repeated drainage more than once every  days
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently) (patients with indwelling catheters such as PleurX are allowed)
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
+Ascites, pleural effusion, or pericardial fluid requiring drainage in the last  weeks prior to registration
+Grade  or higher ascites, pleural, or pericardial effusion within  weeks of study enrollment or any history of recurrent grade  or higher effusions requiring ongoing drainage.
+Uncontrolled pleural or pericardial effusion or ascites that would require recurrent drainage
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)\r\n* Subjects with indwelling drainage catheters are allowed
+Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
+Uncontrolled pleural or pericardial effusion or ascites that would require recurrent drainage
+Uncontrollable pleural effusion, pericardial effusion, or ascites requiring frequent drainage
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures >/= time per month
+Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
+Has significant ascites or pleural effusion requiring drainage for symptom relief
+Uncontrolled effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
+Ascites, pleural effusion or pericardial fluid requiring drainage in the last  weeks
+Patients with large and recurrent pleural or peritoneal effusions requiring frequent drainage (e.g. weekly); patients with any amount of clinically significant pericardial effusion
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring drainage at least once monthly.
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently); participants with indwelling catheters are eligible
+Subjects with ascites or pleural effusion requiring drainage within the last  days.
+Uncontrolled pleural, pericardial effusions, or ascites requiring recurrent drainage procedures
+Uncontrolled pleural effusion, pericardial effusion, or ascites (indwelling drainage catheters allowed)
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)
+Uncontrolled tumor-related pain or uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent (once monthly or more frequently) drainage procedures
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
+Patients with a pleural effusion requiring continuous drainage
+Symptomatic pleural effusion (> CTCAE Grade  dyspnea) that is not amenable to drainage
+Patients require regular ascites/pleural effusion drainage
+Patient with pleural effusion, ascites, or pericardial fluid requiring drainage.
+Patient has pleural effusion, ascites, or pericardial fluid requiring drainage. Note: Patient who had drain removal ?  days prior to planned first dose of study drug and has no sign of worsening is eligible.
+Pleural effusion requiring repetitive drainage, i.e., an indwelling catheter or  thoracenteses with  weeks of the first dose of mogamulizumab;
+Pleural effusion, pericardial fluid, or ascites requiring drainage every other week or more frequently
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures
+No effusion or ascites >  L prior to drainage
+Uncontrolled pleural effusion, pericardial effusion or ascites requiring recurrent drainage procedures
+Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)